EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Clinically Meaningful Differences for Cough-Specific Visual Analogue Scale in Chronic Cough: A Real-World Study

Mami Rikimaru, Junpei Saito, Surinder S Birring, Atsuro Fukuhara, Yasuhito Suzuki, Ryuki Yamada, Tetsuya Egawa, Takahiro Kumanaka, Ryutaro Tanaka, Kentaro Kazama, Koshi Saito, Rina Harigane und 12 weitere

Lung · 17.06.2026 · 204 (1)

DOI: 10.1007/s00408-026-00898-8 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Lung, online erschienen am 17.06.2026. Verfasst von Mami Rikimaru und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonary Medicine, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima City, Fukushima Prefecture, 960-1295, Jap…. Hauptthemen laut MEDLINE: Chronic Cough, Visual Analog Scale, Minimal Clinically Important Difference, Cough. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cough-specific visual analogue scale (VAS) is widely used to assess cough severity and frequency; however, clinically meaningful thresholds for treatment response in chronic cough (CC) remain uncertain in routine practice. OBJECTIVES: To determine minimum clinically important differences (MCIDs) for cough VAS severity and frequency using real-world data anchored to both objective cough frequency and patient-reported quality of life. METHODS: In this prospective observational study, 103 patients with CC were evaluated before and after standard treatment. Cough severity and frequency were assessed using 100-mm VAS, health-related quality of life using the Leicester Cough Questionnaire (LCQ), and 24-hour cough frequency (CoFr24) using the Leicester Cough Monitor. MCIDs for absolute (ΔVAS) and percentage (%ΔVAS) changes were estimated by receiver operating characteristic analyses, anchored to established MCIDs for LCQ (≥ 1.3-points increase) and CoFr24 (≥ 30% reduction). RESULTS: VAS severity and frequency showed moderate, statistically significant correlations with both LCQ and CoFr24. Anchor-based analyses consistently identified an absolute MCID of approximately -24 mm for both VAS domains, irrespective of anchor selection. Percentage-based MCIDs converged at a 60-65% reduction. These thresholds demonstrated acceptable discriminative ability (sensitivity of 70-80%, specificity of 65-90%) and remained consistent across objective and patient-reported anchors in a heterogeneous CC population. CONCLUSIONS: In the present study, both ΔVAS of 24 mm and %ΔVAS of 60-65% reduction in cough VAS represented clinically meaningful improvement. Percentage-based MCIDs may complement absolute thresholds across a range of baseline severity, supporting the use of VAS in clinical practice and trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic CoughVisual Analog ScaleMinimal Clinically Important DifferenceCoughHumansFemaleProspective StudiesMaleMiddle AgedSeverity of Illness IndexQuality of LifeAgedAdultROC CurveSurveys and QuestionnairesPatient Reported Outcome Measures

Stichwörter der Autor:innen

Chronic coughClinically minimum important differenceLeicester cough monitorLeicester cough questionnaireReal-world studyVisual analogue scale

Autor:innen und Institutionen

  • Department of Pulmonary Medicine, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima City, Fukushima Prefecture, 960-1295, Japan.
  • Department of Pulmonary Medicine, Fukushima Medical University School of Medicine, 1 Hikarigaoka, Fukushima City, Fukushima Prefecture, 960-1295, Japan. junpei@fmu.ac.jp.
  • Centre for Human and Applied Physiological Sciences, School of Basic and Medical Biosciences, King's College London, London, UK.
  • Department of Respiratory Medicine, King's College Hospital, London, UK.

Zitieren

APA

Rikimaru, M., Saito, J., Birring, S. S., Fukuhara, A., Suzuki, Y., Yamada, R., Egawa, T., Kumanaka, T., Tanaka, R., Kazama, K., Saito, K., Harigane, R., Sato, R., Tomita, H., Watanabe, N., Umeda, T., Togawa, R., Sato, Y., Wang, X., …, & Shibata, Y. (2026). Clinically Meaningful Differences for Cough-Specific Visual Analogue Scale in Chronic Cough: A Real-World Study. Lung, 204(1). https://doi.org/10.1007/s00408-026-00898-8

Vancouver

Rikimaru M, Saito J, Birring SS, Fukuhara A, Suzuki Y, Yamada R, et al. Clinically Meaningful Differences for Cough-Specific Visual Analogue Scale in Chronic Cough: A Real-World Study. Lung. 2026;204(1). doi:10.1007/s00408-026-00898-8

BibTeX
@article{Rikimaru2026,
  author = {Rikimaru, Mami and Saito, Junpei and Birring, Surinder S and Fukuhara, Atsuro and Suzuki, Yasuhito and Yamada, Ryuki and Egawa, Tetsuya and Kumanaka, Takahiro and Tanaka, Ryutaro and Kazama, Kentaro and Saito, Koshi and Harigane, Rina and Sato, Riko and Tomita, Hikaru and Watanabe, Natsumi and Umeda, Takashi and Togawa, Ryuichi and Sato, Yuki and Wang, Xintao and Nikaido, Takefumi and Fukuhara, Naoko and Kanazawa, Kenya and Tanino, Yoshinori and Shibata, Yoko},
  title = {Clinically Meaningful Differences for Cough-Specific Visual Analogue Scale in Chronic Cough: A Real-World Study},
  journal = {Lung},
  year = {2026},
  volume = {204},
  number = {1},
  doi = {10.1007/s00408-026-00898-8}
}
Kostenlos starten →